These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar. I. Study in two regions of the west coast]. Deloron P, Ramanamirija JA, Le Bras J, Verdier P, Coulanges P. Arch Inst Pasteur Madagascar; 1984; 51(1):29-42. PubMed ID: 6398672 [Abstract] [Full Text] [Related]
3. [4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar. III. Studies in three regions of the interior]. Deĺoron P, Ramanamirija JA, Le Bras J, Coulanges P. Arch Inst Pasteur Madagascar; 1984; 51(1):57-68. PubMed ID: 6398674 [Abstract] [Full Text] [Related]
4. [In vivo and in vitro sensitivity to 4-aminoquinolines of Plasmodium falciparum in Madagascar: results of 2 years' study]. Ramanamirija JA, Deloron P, Biaud JM, Le Bras J, Coulanges P. Bull Soc Pathol Exot Filiales; 1985; 78(5):606-14. PubMed ID: 3910289 [Abstract] [Full Text] [Related]
5. [In vivo and in vitro sensitivity to 4-aminoquinolines of Plasmodium falciparum in Madagascar: results of a study conducted on the east coast (July 1985-July 1986)]. Marchais H, Ramanamirija JA, Le Bras J, Coulanges P. Arch Inst Pasteur Madagascar; 1987; 53(1):43-62. PubMed ID: 3330414 [No Abstract] [Full Text] [Related]
8. Resistance of Plasmodium falciparum malaria to amodiaquine, chloroquine and quinine in the Madang Province of Papua New Guinea, 1990-1993. al-Yaman F, Genton B, Mokela D, Narara A, Raiko A, Alpers MP. P N G Med J; 1996 Mar; 39(1):16-22. PubMed ID: 9522846 [Abstract] [Full Text] [Related]
13. In-vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar. Randrianarivelojosia M, Ratsimbasoa A, Randrianasolo L, Randrianarijaona A, Jambou R. East Afr Med J; 2002 May; 79(5):237-41. PubMed ID: 12638806 [Abstract] [Full Text] [Related]
14. [Sensitivity of Plasmodium falciparum to quinolines and therapeutic strategies: comparison of the situation in Africa and Madagascar between 1983 and 1986]. Le Bras J, Simon F, Ramanamirija JA, Calmel MB, Hatin I, Deloron P, Porte J, Marchais H, Clausse JL, Biaud JM. Bull Soc Pathol Exot Filiales; 1987 May; 80(3 Pt 2):477-89. PubMed ID: 3319258 [Abstract] [Full Text] [Related]
16. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea. Genton B, Baea K, Lorry K, Ginny M, Wines B, Alpers MP. P N G Med J; 2005 May; 48(3-4):141-50. PubMed ID: 17212060 [Abstract] [Full Text] [Related]
17. 4-Aminoquinoline resistance of Plasmodium falciparum: insights from the study of amodiaquine uptake. Bray PG, Hawley SR, Ward SA. Mol Pharmacol; 1996 Dec; 50(6):1551-8. PubMed ID: 8967977 [Abstract] [Full Text] [Related]
18. Response of falciparum malaria to chloroquine and three second line antimalarial drugs in a Kenyan coastal school age population. Hagos B, Khan B, Ofulla AV, Kariuki D, Martin SK. East Afr Med J; 1993 Oct; 70(10):620-3. PubMed ID: 8187656 [Abstract] [Full Text] [Related]
20. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea. Marfurt J, Müeller I, Sie A, Maku P, Goroti M, Reeder JC, Beck HP, Genton B. Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359 [Abstract] [Full Text] [Related] Page: [Next] [New Search]